Evidence map›Paper›PMID 28347271›Full record

ArticleBMC microbiology2017

The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone.

Marie-Hélène Nicolas-Chanoine, Marie Petitjean, Azucena Mora, Noémie Mayer, Jean-Philippe Lavigne, Olivier Boulet, Véronique Leflon-Guibout, Jorge Blanco, Didier Hocquet

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Higher prevalence of CTX-M-27-producing Escherichia coli belonging to ST131 clade C1 among residents of two long-term care facilities in Southern Spain.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
  6. Review
  7. Article
  8. Antibiotic-ResistantMicroorganisms · 2020
    Article
  9. Genomic Surveillance of Ceftriaxone-ResistantFrontiers in microbiology · 2020
    Article
  10. Whole Genome Sequencing and Characteristics ofFrontiers in microbiology · 2020
    Article
  11. Article
  12. Clonal ST131-Microbial genomics · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Marie-Hélène Nicolas-ChanoineService de Microbiologie, Hôpital Beaujon, AP-HP, Clichy, France. mhn.chanoine@aphp.fr.
Marie PetitjeanLaboratoire d'Hygiène Hospitalière, CHRU Besançon, Besançon, France.
Azucena MoraLaboratorio de Referencia de E. coli (LREC), Facultad de Veterinaria, Universidad de Santiago de Compostela, Lugo, Spain.
Noémie MayerService de Microbiologie, Hôpital Beaujon, AP-HP, Clichy, France.
Jean-Philippe LavigneInstitut National de la Santé et de la Recherche Médicale, U1047, Université de Montpellier, UFR de Médecine, Nîmes, France.
Olivier BouletLaboratoire d'Analyse Médicale du Centre, Coulommiers, France.
Véronique Leflon-GuiboutService de Microbiologie, Hôpital Beaujon, AP-HP, Clichy, France.
Jorge BlancoLaboratorio de Referencia de E. coli (LREC), Facultad de Veterinaria, Universidad de Santiago de Compostela, Lugo, Spain.
Didier HocquetLaboratoire d'Hygiène Hospitalière, CHRU Besançon, Besançon, France.
Centre Hospitalier Universitaire de Besançon · FRHôpital Beaujon · FRInserm · FRUniversidade de Santiago de Compostela · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2006, we found healthy subjects carrying ST131 Escherichia coli in their intestinal microbiota consisting of two populations: a subdominant population of fluoroquinolone-resistant E. coli belonging to subclone H30 (H30-R or subclade C1), the current worldwide dominant ST131 subclone, and a dominant E. coli population composed of antibiotic-susceptible E. coli belonging to subclone H22 (clade B), the precursor of subclone H30. We sequenced the whole genome of fecal H22 strain S250, compared it to the genomes of ExPEC ST131 H30-Rx strain JJ1886 and commensal ST131 H41 strain SE15, sought the H22-H30 genomic differences in our fecal strains and assessed their phenotypic consequences.

resultsWe detected 173 genes found in the Virulence Factor Database, of which 148 were shared by the three ST131 genomes, whereas some were genome-specific, notably those allowing determination of virotype (D for S250 and C for JJ1886). We found three sequences of the FimH site involved in adhesion: two in S250 and SE15 close and identical, respectively, to that previously reported to confer strong intestinal adhesion, and one in JJ1886, corresponding to that commonly present in uropathogenic E. coli. Among the genes involved in sugar metabolism, one encoding a gluconate kinase lacked in S250 and JJ1886. Although this gene was also absent in both our fecal H22 and H30-R strains, H22 strains showed a higher capacity to grow in minimal medium with gluconate. Among the genes involved in gluconate metabolism, only the ghrB gene differed between S250/H22 and JJ1886/H30-R strains, resulting in different gluconate reductases. Of the genes involved in biofilm formation, two were absent in the three genomes and one, fimB, in the JJ1886 genome. Our fecal H30-R strains lacking intact fimB displayed delayed biofilm formation relative to our fecal H22 strains. The H22 strains differed by subclade B type and plasmid content, whereas the H30-R strains were identical.

conclusionsPhenotypic analysis of our fecal strains based on observed genomic differences between S250 and JJ1886 strains suggests the presence of traits related to bacterial commensalism in our H22 strains and traits commonly found in uropathogenic E. coli in our H30-R strains.

Indexed as

Gastrointestinal MicrobiomeGenomicsPhenotypeAdhesins, Escherichia coliAnti-Bacterial AgentsBacterial AdhesionBiofilmsCarbonDNA, BacterialDNA-Binding ProteinsDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsExtraintestinal Pathogenic Escherichia coliFecesAdhesins, Escherichia coliAnti-Bacterial AgentsCarbonDNA, BacterialDNA-Binding ProteinsEscherichia coli ProteinsfimB protein, E coliFimbriae ProteinsfimH protein, E coliFluoroquinolonesGluconatesgluconic acidgluconokinaseIntegrasesMethyltransferasesNutritive SweetenersPhosphotransferases (Alcohol Group Acceptor)Virulence FactorsBiofilmE. coli ST131H22 genomeMannose-binding FimH regionPlasmid repliconsSubclades BSugar metabolism

Identifiers

PMID28347271
PMCPMC5369007
OpenAlexW2598128465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.